Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableActive Not RecruitingNCT02747485
What this trial is testing

Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)

Who this might be right for
Valve Heart Diseases
Assistance Publique Hopitaux De Marseille 316
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Not applicableEnded earlyNCT02086708
What this trial is testing

Ultrasound Method to Measure Fibrosis of the Liver in Children

Who this might be right for
Chronic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHCV Coinfection+2 more
Massachusetts General Hospital 24
Not applicableStudy completedNCT01462006
What this trial is testing

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisDiffuse Parenchymal Lung DiseaseInterstitial Lung Disease
University of Virginia 32
Testing effectiveness (Phase 2)Study completedNCT00129428
What this trial is testing

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Who this might be right for
KeloidScleroderma, LocalizedAcne Keloidalis+2 more
University of Michigan 33
Not applicableStudy completedNCT01729611
What this trial is testing

Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
The Cleveland Clinic 119
Not applicableStudy completedNCT00453713
What this trial is testing

Race, Ethnicity, and Diffuse Parenchymal Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseDiffuse Parenchymal Lung Disease
Columbia University 565
Not applicableStudy completedNCT02350829
What this trial is testing

T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease

Who this might be right for
Cardiomyopathy
The Hospital for Sick Children 65
Not applicableStudy completedNCT03141125
What this trial is testing

The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy

Who this might be right for
Scleroderma
Universitas Indonesia 62
Not applicableStudy completedNCT03207997
What this trial is testing

MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients

Who this might be right for
Scleroderma
Assistance Publique - Hôpitaux de Paris 24
Not applicableNot Yet RecruitingNCT07530562
What this trial is testing

A Health Coach-Led Digital Lifestyle Intervention (HEALDI)

Who this might be right for
Myocardial FibrosisLeft Ventricle HypertrophyHypertensive Disease+1 more
National University of Singapore 200
Not applicableUnknownNCT04626492
What this trial is testing

Quantitative MRI Imaging in Diffuse Liver Diseases

Who this might be right for
Fibrosis and Cirrhosis of Liver
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Testing effectiveness (Phase 2)Study completedNCT00613171
What this trial is testing

Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis, Scleroderma
Novartis Pharmaceuticals 27